CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: molecular messenger
Accession: CHEBI:33280
browse the term
Synonyms: related_synonym: chemical messenger
G
NPPA
natriuretic peptide A
affects abundance
EXP
NPPA protein affects the abundance of Epinephrine
CTD
PMID:2951327
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
ADRB1
adrenoceptor beta 1
increases activity
EXP
Norepinephrine results in increased activity of ADRB1 protein
CTD
PMID:10344530
NCBI chr28:24,908,224...24,909,684
Ensembl chr28:24,908,224...24,909,684
G
ADRB2
adrenoceptor beta 2
multiple interactions
EXP
[Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased secretion of Norepinephrine
CTD
PMID:2884805
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
G
NPPA
natriuretic peptide A
increases expression
EXP
Norepinephrine results in increased expression of NPPA protein
CTD
PMID:8952593
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions increases activity
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased activity of PIK3CG protein]; [Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate
CTD
PMID:15958164
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
POMC
proopiomelanocortin
increases response to substance
EXP
POMC protein results in increased susceptibility to Norepinephrine
CTD
PMID:6279499
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
PRKCZ
protein kinase C zeta
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased phosphorylation of PRKCZ protein]
CTD
PMID:15958164
NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
G
REN
renin
increases activity
EXP
Norepinephrine results in increased activity of REN protein
CTD
PMID:8952593
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
PLCG1
phospholipase C gamma 1
decreases activity multiple interactions
EXP
1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein]
CTD
PMID:2001791
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Dithiothreitol metabolite results in increased expression of HSPA5 protein
CTD
PMID:17416481
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
G
ABCC2
ATP binding cassette subfamily C member 2
affects transport
EXP
ABCC2 protein affects the transport of Estradiol
CTD
PMID:15507541
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
G
ESR1
estrogen receptor 1
affects expression
EXP
Estradiol affects the expression of ESR1 protein
CTD
PMID:16483645
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of estradiol-17 beta-glucuronide
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
G
SOD2
superoxide dismutase 2
multiple interactions
EXP
Dihydrotestosterone promotes the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein]
CTD
PMID:16682413
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
KCNJ3
potassium inwardly rectifying channel subfamily J member 3
multiple interactions
EXP
Acetylcholine promotes the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]
CTD
PMID:10666054
NCBI chr36:1,354,686...1,496,397
Ensembl chr36:1,354,678...1,493,766
G
KCNJ6
potassium inwardly rectifying channel subfamily J member 6
multiple interactions
EXP
Acetylcholine promotes the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]
CTD
PMID:10666054
NCBI chr31:32,752,585...33,010,999
Ensembl chr31:32,755,899...32,934,478
G
MAPK14
mitogen-activated protein kinase 14
multiple interactions
EXP
Acetylcholine results in increased phosphorylation of and results in increased activity of MAPK14 protein
CTD
PMID:9688607
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Aspirin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
AGT
angiotensinogen
increases abundance
EXP
AGT results in increased abundance of Aldosterone
CTD
PMID:2831029
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
POMC
proopiomelanocortin
increases abundance
EXP
POMC protein results in increased abundance of Aldosterone
CTD
PMID:2831029
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
CASP3
caspase 3
increases activity
EXP
Tretinoin results in increased activity of CASP3 protein
CTD
PMID:16953078
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CLDN1
claudin 1
multiple interactions increases expression
EXP
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA] Tretinoin results in increased expression of CLDN1 mRNA; Tretinoin results in increased expression of CLDN1 protein
CTD
PMID:17035595
NCBI chr34:22,303,058...22,319,101
Ensembl chr34:22,303,850...22,319,033
G
CLDN4
claudin 4
increases expression multiple interactions
EXP
Tretinoin results in increased expression of CLDN4 mRNA; Tretinoin results in increased expression of CLDN4 protein CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA]
CTD
PMID:17035595
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
CYP26A1
cytochrome P450 family 26 subfamily A member 1
increases degradation multiple interactions
EXP
CYP26A1 protein results in increased degradation of Tretinoin CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of OCLN mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of TJP1 mRNA]
CTD
PMID:17035595
NCBI chr28:7,423,955...7,432,359
Ensembl chr28:7,428,772...7,432,370
G
NOS3
nitric oxide synthase 3
increases expression
EXP
Tretinoin results in increased expression of NOS3 mRNA; Tretinoin results in increased expression of NOS3 protein
CTD
PMID:17267746
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
OCLN
occludin
multiple interactions increases expression
EXP
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of OCLN mRNA] Tretinoin results in increased expression of OCLN mRNA; Tretinoin results in increased expression of OCLN protein
CTD
PMID:17035595
NCBI chr 2:54,500,299...54,545,430
Ensembl chr 2:54,500,299...54,545,430
G
TJP1
tight junction protein 1
increases expression multiple interactions
EXP
Tretinoin results in increased expression of TJP1 mRNA; Tretinoin results in increased expression of TJP1 protein CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of TJP1 mRNA]
CTD
PMID:17035595
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
G
ACHE
acetylcholinesterase
multiple interactions
EXP
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX results in decreased activity of ACHE protein]
CTD
PMID:16915560
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
SCT
secretin
multiple interactions
EXP
Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates]
CTD
PMID:3562434
G
BCL2
BCL2 apoptosis regulator
affects expression
EXP
Calcitriol affects the expression of BCL2 protein
CTD
PMID:16080513
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
INS
insulin
increases abundance
EXP
INS protein results in increased abundance of Adrenocorticotropic Hormone
CTD
PMID:1646414
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
G
CRH
corticotropin releasing hormone
increases abundance
EXP
CRH protein results in increased abundance of Hydrocortisone
CTD
PMID:2831029
NCBI chr29:15,831,944...15,840,560
Ensembl chr29:15,831,944...15,834,384
G
INS
insulin
affects abundance multiple interactions
EXP
INS protein affects the abundance of Hydrocortisone Sodium affects the reaction [INS protein affects the abundance of Hydrocortisone]
CTD
PMID:1324617
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
G
POMC
proopiomelanocortin
increases abundance
EXP
POMC protein results in increased abundance of Hydrocortisone
CTD
PMID:2831029
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
AVP
arginine vasopressin
decreases expression
EXP
Dexamethasone results in decreased expression of AVP protein
CTD
PMID:1934541
NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
increases expression
EXP
Dexamethasone results in increased expression of HSD11B1 mRNA
CTD
PMID:21798686
NCBI chr 7:8,344,380...8,409,901
Ensembl chr 7:8,344,447...8,409,897
G
NPPA
natriuretic peptide A
increases expression
EXP
Dexamethasone results in increased expression of NPPA protein
CTD
PMID:1934541
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
CYP2C18
cytochrome P450 2C21
increases hydroxylation
EXP
CYP2C19 protein results in increased hydroxylation of Diclofenac
CTD
PMID:15677349
NCBI chr28:8,727,010...8,750,427
Ensembl chr28:8,727,019...8,750,587
G
CYP2C41
cytochrome P450 2C41
affects metabolic processing
EXP
CYP2C9 protein affects the metabolism of Diclofenac
CTD
PMID:15801540
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Diclofenac results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
ALPI
alkaline phosphatase, intestinal
increases chemical synthesis
EXP
ALPI protein results in increased chemical synthesis of Estrone
CTD
PMID:1495895
NCBI chr25:44,107,418...44,110,947
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
increases transport
EXP
SLCO1B3 protein results in increased transport of estrone sulfate
CTD
PMID:20079461
NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
G
CFTR
CF transmembrane conductance regulator
decreases activity
EXP
Genistein results in decreased activity of CFTR protein
CTD
PMID:15496164
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
G
CPNE6
copine 6
decreases activity
EXP
Genistein results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
G
CLDN4
claudin 4
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]
CTD
PMID:23816505
NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23816505
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23816505
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]
CTD
PMID:23816505
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions
EXP
Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]
CTD
PMID:23816505
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
G
NOS3
nitric oxide synthase 3
increases activity
EXP
icariin results in increased activity of NOS3 protein
CTD
PMID:17438405
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Dithiothreitol metabolite results in increased expression of HSPA5 protein
CTD
PMID:17416481
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
G
KNG1
kininogen 1
increases activity
EXP
Nitric Oxide deficiency results in increased activity of KNG1 protein modified form
CTD
PMID:10805402
NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
G
WT1
WT1 transcription factor
multiple interactions
EXP
[Nitroprusside results in increased abundance of Nitric Oxide] which results in increased expression of WT1 mRNA
CTD
PMID:21443142
NCBI chr18:35,099,660...35,148,767
Ensembl chr18:35,103,934...35,148,000
G
REN
renin
decreases secretion multiple interactions
EXP
Ouabain results in decreased secretion of REN protein Vanadates inhibits the reaction [Ouabain results in decreased secretion of REN protein]
CTD
PMID:6093556
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
ESR1
estrogen receptor 1
affects expression
EXP
Progesterone affects the expression of ESR1 protein
CTD
PMID:16483645
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
PGR
progesterone receptor
affects binding
EXP
Progesterone binds to PGR protein
CTD
PMID:16054490
NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]
CTD
PMID:15266218
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
CPNE6
copine 6
decreases activity
EXP
Quercetin results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
G
HSP70
heat shock protein 70
decreases expression
EXP
Quercetin results in decreased expression of HSP70 protein
CTD
PMID:17009600
NCBI chr12:1,285,282...1,287,670
G
AHR
aryl hydrocarbon receptor
multiple interactions
EXP
[salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin
CTD
PMID:24389113
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
AGT
angiotensinogen
increases response to substance multiple interactions
EXP
AGT protein modified form results in increased susceptibility to Serotonin Deferoxamine inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]; Reactive Oxygen Species inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]
CTD
PMID:8021468
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
EDN1
endothelin 1
increases activity
EXP
Serotonin results in increased activity of EDN1 protein
CTD
PMID:9918753
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
GSR
glutathione-disulfide reductase
multiple interactions
EXP
[monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
CTD
PMID:18163546
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
B9D2
B9 domain containing 2
increases expression
EXP
Testosterone results in increased expression of TGFB1 mRNA
CTD
PMID:17157324
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
KCND3
potassium voltage-gated channel subfamily D member 3
increases expression
EXP
Testosterone results in increased expression of KCND3 protein
CTD
PMID:17054656
NCBI chr17:63,470,829...63,668,354
Ensembl chr17:63,470,415...63,668,035
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
increases expression
EXP
Testosterone results in increased expression of KCNJ2 protein
CTD
PMID:17054656
NCBI chr 9:16,468,938...16,475,722
Ensembl chr 9:16,468,938...16,475,722
G
ACHE
acetylcholinesterase
multiple interactions
EXP
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX results in decreased activity of ACHE protein]
CTD
PMID:16915560
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
SCT
secretin
multiple interactions
EXP
Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates]
CTD
PMID:3562434
G
INS
insulin
multiple interactions
EXP
INS protein promotes the reaction [Sodium results in increased abundance of Vasopressins]
CTD
PMID:1324617
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
G
ABCG2
ATP binding cassette subfamily G member 2
increases transport
EXP
ABCG2 protein results in increased transport of Zearalenone
CTD
PMID:30576553
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all